Moderna, Inc. (NASDAQ:MRNA) will release earnings results for its third quarter, before the opening bell on Thursday, Nov. 7. Analysts expect the Cambridge, Massachusetts-based company to report a quarterly loss at $1.9 per share, versus a year-ago loss of $9.53 per share. Moderna projects to report revenue of $1.25 billion for the quarter, compared to $1.83 billion a year earlier, according to data from Benzinga Pro. On Oct. 28, On Monday, Merck & Co Inc (NYSE:MRK) and Moderna announced the initiation of INTerpath-009, a pivotal Phase 3 trial of V940 (mRNA-4157). Moderna shares fell 2.8% to c…
